Beretta Giovanni L, Ribaudo Giovanni, Menegazzo Ileana, Supino Rosanna, Capranico Giovanni, Zunino Franco, Zagotto Giuseppe
Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Arch Pharm (Weinheim). 2017 Jan;350(1). doi: 10.1002/ardp.201600286. Epub 2016 Dec 19.
DNA topoisomerase I inhibitors, both synthetic and of natural origin, are receiving increasing consideration primarily as drugs against refractory tumors. Alkannin and shikonin, two enantiomeric dyes from Alkanna tinctoria and Lithospermum erythrorhizon, have been known over many centuries as dyestuff, wound healing, anti-inflammatory, antibacterial and antitumor substances. Although multiple mechanisms appear to be implicated, their potency is associated with the inhibition of topoisomerase I and with the redox properties of the naphthazarin scaffold. Here, the synthesis of new naphthalene and naphthoquinone derivatives inspired by alkannin and shikonin is described and their structural and biological properties were examined. Different oxidation states of the naphthalene nucleus were examined to observe the effect of this parameter on cytotoxicity. Antiproliferative activities against a panel of human cancer cell lines were evaluated and the implication of topoisomerase I was assessed.
DNA拓扑异构酶I抑制剂,包括合成的和天然来源的,正越来越多地被视为主要用于治疗难治性肿瘤的药物。紫朱草素和紫草素是来自紫朱草和紫草的两种对映体染料,几个世纪以来一直作为染料、伤口愈合剂、抗炎、抗菌和抗肿瘤物质为人所知。尽管似乎涉及多种机制,但其效力与拓扑异构酶I的抑制以及萘并萘醌支架的氧化还原性质有关。在此,描述了受紫朱草素和紫草素启发的新萘和萘醌衍生物的合成,并研究了它们的结构和生物学性质。研究了萘核的不同氧化态,以观察该参数对细胞毒性的影响。评估了对一组人类癌细胞系的抗增殖活性,并评估了拓扑异构酶I的作用。